JOURNAL ARTICLE
RESEARCH SUPPORT, NON-U.S. GOV'T
Add like
Add dislike
Add to saved papers

Optimization of conventional Fenton and ultraviolet-assisted oxidation processes for the treatment of reverse osmosis retentate from a paper mill.

According to current environmental legislation concerned with water scarcity, paper industry is being forced to adopt a zero liquid effluent policy. In consequence, reverse osmosis (RO) systems are being assessed as the final step of effluent treatment trains aiming to recover final wastewater and reuse it as process water. One of the most important drawbacks of these treatments is the production of a retentated stream, which is usually highly loaded with biorecalcitrant organic matter and inorganics; and this effluent must meet current legislation stringent constraints before being ultimately disposed. The treatment of biorefractory RO retentate from a paper mill by several promising advanced oxidation processes (AOPs) - conventional Fenton, photo-Fenton and photocatalysis - was optimized considering the effect and interaction of reaction parameters; particularly using response surface methodology (RSM) when appropriate (Fenton processes). The economical cost of these treatments was also comparatively assessed. Photo-Fenton process was able to totally remove the COD of the retentate, and resulted even operatively cheaper at high COD removal levels than conventional Fenton, which achieved an 80% reduction of the COD at best. In addition, although these optimal results were produced at pH=2.8, it was also tested that Fenton processes are able to achieve good COD reduction efficiencies (>60%) without adjusting the initial pH value, provided the natural pH of this wastewater was close to neutral. Finally, although TiO(2)-photocatalysis showed the least efficient and most expensive figures, it improved the biodegradability of the retentate, so its combination with a final biological step almost achieved the total removal of the COD.

Full text links

We have located links that may give you full text access.
Can't access the paper?
Try logging in through your university/institutional subscription. For a smoother one-click institutional access experience, please use our mobile app.

For the best experience, use the Read mobile app

Mobile app image

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app

All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.

By using this service, you agree to our terms of use and privacy policy.

Your Privacy Choices Toggle icon

You can now claim free CME credits for this literature searchClaim now

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app